Leqembi: Five insights on the first fully approved Alzheimer's drug

Leqembi was just approved to treat early stage Alzheimer's. In this solo episode, host David Williams shares five thoughts.

1. Leqembi is just different enough from Aduhelm to survive scrutiny
2. Patient registry requirement is a good idea
3. The delivery system isn't ready
4. Health equity will suffer
5. Public health and prevention would be money better spent

As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

• Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
• Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
• YouTube https://www.youtube.com/@CareTalkPodcast
• CareTalk website https://www.caretalkpodcast.com/

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.